Pieter has worked in the field of pharmaceuticals and life sciences since 2004. He has worked as an independent advisor for a broad range of clients, both in the Netherlands and abroad since 2010.
Kevin has completed the study Bio-pharmaceutical Science with a master specialisation in Science Based Business at Leiden University. He has joined Exon Consultancy in 2013 and is currently taking part in the PhD-programme for professionals at the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation.
“Exons, a term derived from expressed regions, are pieces of DNA. They are the parts of the genome that are expressed and contain the information for making proteins: exons form the blueprint for life. Exon Consultancy works with a similar approach: we select valuable information and convert it into applications that make a difference.”